NCT01639924

Brief Summary

Background: \- Gastrointestinal diseases and disorders affect the throat, stomach, and intestines. There are many different kinds of these diseases. Clinical trials are being developed to study new ways to treat them. People who are interested in clinical trials need to be screened before they can take part in the studies. Researchers want to evaluate people with different stomach and intestine disorders to see if they are eligible for clinical trials. Objectives: \- To study people who have gastrointestinal disorders and see if they are eligible for clinical trials. Eligibility: \- Individuals at least 18 years of age who have or may have a gastrointestinal disorder. Design:

  • Participants will be screened with a physical exam and medical history. Blood, urine, and stool samples will be collected. Imaging studies such as x-rays and ultrasound will check to see if the disorder has affected other organs.
  • Participants may have tests as needed depending on their disorder. These tests include the following:
  • Colonoscopy and endoscopy of the large intestine, esophagus, and stomach.
  • Stomach acid analysis to look at stomach pH levels.
  • Wireless capsule endoscopy to take pictures of the small intestine.
  • Hydrogen breath testing to study issues like bloating, diarrhea, and constipation.
  • Sitz Marker Study to see how fast stool moves through the colon.
  • Participants may donate extra blood, urine, or stool samples for study. They may also donate stomach contents or tissue from the gut.
  • Treatment will not be provided as part of this study. However, participants may be admitted to other clinical trials.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,761

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 13, 2012

Completed
14 days until next milestone

Study Start

First participant enrolled

July 27, 2012

Completed
9.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2022

Completed
Last Updated

February 18, 2022

Status Verified

February 1, 2022

Enrollment Period

9.6 years

First QC Date

July 11, 2012

Last Update Submit

February 16, 2022

Conditions

Keywords

Upper GI DiseaseSmall Bowel DiseaseDigestive DiseaseGastrointestinal DiseaseLower GI DiseaseNatural History

Outcome Measures

Primary Outcomes (1)

  • Patients with gastrointestinal disease

    screening protocol for gastrointestinal diseases.

    until protocol closes

Secondary Outcomes (1)

  • Allow outpatient evaluation and follow-up of patients with a variety of gastrointestinal diseases for the purposes of physician education in the NIDDK's accredited gastroenterology training program.

    until protocol closes

Study Arms (1)

Study Cohort

Patients with known or suspected gastrointestinal disease

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with known or suspected gastrointestinal disease.@@@@@@

You may qualify if:

  • Known or suspected gastrointestinal disorders.
  • Patients greater than or equal to 18 years of age capable of providing informed consent.
  • Existence of a referring community physician who would be able to manage care outside of the NIH.

You may not qualify if:

  • Significant medical illnesses that the investigators feel may interfere with potential evaluations.
  • Any medical, psychiatric, or social conditions which, in the opinion of the investigators, would make participation in this protocol not in the best interest of the patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

Related Links

MeSH Terms

Conditions

Gastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Sheila Kumar, M.D.

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2012

First Posted

July 13, 2012

Study Start

July 27, 2012

Primary Completion

February 15, 2022

Study Completion

February 15, 2022

Last Updated

February 18, 2022

Record last verified: 2022-02

Locations